The latest price target for Cargo Therapeutics (NASDAQ:CRGX) was reported by William Blair on November 26, 2024. The analyst firm set a price target for $0.00 expecting CRGX to fall to within 12 months (a possible -100.00% downside). 14 analyst firms have reported ratings in the last year.

The latest analyst rating for Cargo Therapeutics (NASDAQ:CRGX) was provided by William Blair, and Cargo Therapeutics initiated their outperform rating.

There is no last upgrade for Cargo Therapeutics

There is no last downgrade for Cargo Therapeutics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cargo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cargo Therapeutics was filed on November 26, 2024 so you should expect the next rating to be made available sometime around November 26, 2025.

While ratings are subjective and will change, the latest Cargo Therapeutics (CRGX) rating was a initiated with a price target of $0.00 to $0.00. The current price Cargo Therapeutics (CRGX) is trading at is $17.67, which is out of the analyst’s predicted range.